Early research (Phase 1)UnknownNCT05396326What this trial is testingA Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerWho this might be right forGastric Cancer Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01956149What this trial is testingStudy With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435What this trial is testingXNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Who this might be right forPancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more Astellas Pharma Global Development, Inc. 240
Early research (Phase 1)Study completedNCT00635596What this trial is testingPhase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerWho this might be right forSolid Tumors Amgen Research (Munich) GmbH 65
Testing effectiveness (Phase 2)Looking for participantsNCT07631000What this trial is testingCadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerGastroesophageal-junction Cancer Memorial Sloan Kettering Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT05671822What this trial is testingPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerWho this might be right forHER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Early research (Phase 1)Looking for participantsNCT06773312What this trial is testingBC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.Who this might be right forAdvanced or Metastatic Gastric CancerGastroesophageal Junction Adenocarcinoma Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Ended earlyNCT05161572What this trial is testingPerioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric CancerWho this might be right forStomach NeoplasmsEsophagogastric Junction DisorderNeoadjuvant Therapy+5 more Fudan University 6
Large-scale testing (Phase 3)UnknownNCT01523015What this trial is testingEfficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal Junction Medical University of Lublin 100
Testing effectiveness (Phase 2)Study completedNCT04309578What this trial is testingTrastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGCWho this might be right forGastric or Gastroesophageal Junction(GEJ) Adenocarcinoma Asan Medical Center 28
Testing effectiveness (Phase 2)UnknownNCT06406426What this trial is testingStudy of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albuminWho this might be right forGastric / Gastroesophageal Junction Adenocarcinoma Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT03329690What this trial is testingDS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]Who this might be right forNeoplasm, Gastrointestinal Daiichi Sankyo Co., Ltd. 233
Testing effectiveness (Phase 2)Study completedNCT03852251What this trial is testingAK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaAdvanced Solid TumorsGastroesophageal Junction Adenocarcinoma Akeso 338
Testing effectiveness (Phase 2)Study completedNCT00813072What this trial is testingStudy of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forStomach NeoplasmsEsophageal Neoplasms PharmaEngine 135
Testing effectiveness (Phase 2)Looking for participantsNCT07334431What this trial is testingFruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerWho this might be right forGastric AdenocarcinomaGastric (Stomach) CancerGEJ Adenocarcinoma+3 more Henan Cancer Hospital 45
Not applicableAvailableNCT06048081What this trial is testingEarly Access Program for ZolbetuximabWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06415669What this trial is testingPaclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric/Gastroesophageal Junction Adenocarcinoma The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Ended earlyNCT03707028What this trial is testingEvaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Elevar Therapeutics 12
Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Early research (Phase 1)Study completedNCT04086758What this trial is testingA Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Astellas Pharma China, Inc. 12